Meropenem at recommended dose is a potential risk for seizure in hemodialysis patient.
Journal
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
ISSN: 1319-2442
Titre abrégé: Saudi J Kidney Dis Transpl
Pays: Saudi Arabia
ID NLM: 9436968
Informations de publication
Date de publication:
Historique:
entrez:
10
2
2021
pubmed:
11
2
2021
medline:
28
10
2021
Statut:
ppublish
Résumé
Dosage adjustment of meropenem is usually recommended in hemodialysis (HD) patients and about 30% of meropenem is cleared during regular HD sessions. However, most of the published trials excluded patients on regular HD. Little is known about the accurate dosage of meropenem needed to avoid central nervous system toxicity. Herein, we report a 65-year-old Saudi female, a known case of end-stage renal disease on regular HD, who was admitted because of pyelonephritis and started on meropenem in the recommended dose according to cultures and sensitivity. She developed tonic-clonic convulsions after the 7
Identifiants
pubmed: 33565459
pii: SaudiJKidneyDisTranspl_2020_31_6_1427_308364
doi: 10.4103/1319-2442.308364
doi:
Substances chimiques
Anti-Bacterial Agents
0
Meropenem
FV9J3JU8B1
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM